FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1

F-box and WD repeat domain-containing 7 (FBW7) has been characterized as a tumor suppressor, and its mutation or decreased expression has been observed in many types of human cancers. Our recent studies have uncovered that in pancreatic cancer, the KRAS mutation decreased FBW7 expression through pho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Rep
Main Authors: Hu, Qiangsheng, Qin, Yi, Zhang, Bo, Liang, Chen, Ji, Shunrong, Shi, Si, Xu, Wenyan, Xiang, Jinfeng, Liang, Dingkong, Ni, Quanxing, Yu, Xianjun, Xu, Jin
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652962/
https://ncbi.nlm.nih.gov/pubmed/28765935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5856
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados